Skip to product information
1 of 1

Charak

Charak - Prosteez 20 Tablets

Charak - Prosteez 20 Tablets

Regular price $9.99 USD
Regular price Sale price $9.99 USD
Sale Coming soon
Shipping calculated at checkout.
Charak - Prosteez 20 Tablets

Charak - Prosteez 20 Tablets

Benign prostatic hyperplasia (BPH) is a pervasive disorder in men. It is a noncancerous enlargement of the prostate gland, and it can have symptoms such as difficult urination, urinary tract infections, painful urination, or vague feeling of urination.

Charak Prosteez Tablets is a herbo-mineral formulation that provides isoflavone genistein that has an inhibitory effect on the enzymes responsible for the growth of prostatic tissue. Prosteez helps reduce the prostate's size, eases the urine flow comprehensively, and has anti-oxidant and anti-inflammatory actions. It reduces obstructive; irritative symptoms and is complete support for BPH.

Indications:

  • BPH (Benign Prostate Hyperplasia) Grade I BPH
  • Category III B Prostatitis

Dosage:

2 tablets twice a day for 3 to 6 months

Ingredients:

Each coated tablet contains the following:

Extracts:

  • Saw palmetto (Serenoa repens) 75 mg
  • Kankola (Piper cubeba) 50 mg
  • Guduchi (Tinospora cordifolia) 100 mg
  • Triphala  100 mg
  • Varun (Crataeva nurvala) 200 mg
  • Gokshur (Tribulus terrestris) 200 mg
  • Soya (Glycine Soja) 200 mg
  • Kanchanar (Bauhinia variegata) 250 mg

Powders:

  • Yashad Bhasma 10 mg
  • Shilajit Shuddha 25 mg

Natural products have a holistic effect on the body, treating not just the symptoms but the body as a whole, and may take time for absorption and results. You should allow several weeks to experience their long-lasting benefits.

Images are for representation purposes only.
The actual product may differ.

View full details
  • Free Shipping over $100

    Shop ayurvedic, homeo and aromatherapy products worth over $100 and get free shipping.

  • Express delivery options

    Pick between standard delivery of 15-30 days or express shipping to get your order by priority.